Kate Watabayashi

547 total citations
20 papers, 411 citations indexed

About

Kate Watabayashi is a scholar working on Economics and Econometrics, Oncology and Public Health, Environmental and Occupational Health. According to data from OpenAlex, Kate Watabayashi has authored 20 papers receiving a total of 411 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Economics and Econometrics, 9 papers in Oncology and 6 papers in Public Health, Environmental and Occupational Health. Recurrent topics in Kate Watabayashi's work include Health Systems, Economic Evaluations, Quality of Life (10 papers), Economic and Financial Impacts of Cancer (9 papers) and Neutropenia and Cancer Infections (6 papers). Kate Watabayashi is often cited by papers focused on Health Systems, Economic Evaluations, Quality of Life (10 papers), Economic and Financial Impacts of Cancer (9 papers) and Neutropenia and Cancer Infections (6 papers). Kate Watabayashi collaborates with scholars based in United States, South Africa and Puerto Rico. Kate Watabayashi's co-authors include Veena Shankaran, Scott D. Ramsey, Alan Balch, Karen Overstreet, Hannah M. Linden, Kathleen D. Gallagher, Dan Sherman, Todd Yezefski, Karma L. Kreizenbeck and Naomi Schwartz and has published in prestigious journals such as Journal of Clinical Oncology, Cancer and BMC Medical Research Methodology.

In The Last Decade

Kate Watabayashi

18 papers receiving 407 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Kate Watabayashi United States	8	309	89	86	71	69	20	411
Naomi Schwartz United States	8	161 0.5×	51 0.6×	100 1.2×	75 1.1×	40 0.6×	36	345
Kevin Houck United States	9	184 0.6×	38 0.4×	82 1.0×	31 0.4×	22 0.3×	14	275
S Nasso United States	7	93 0.3×	74 0.8×	129 1.5×	29 0.4×	52 0.8×	13	259
Alina Zalounina Falborg Denmark	9	42 0.1×	43 0.5×	162 1.9×	36 0.5×	39 0.6×	28	252
Anupriya Agarwal Australia	5	60 0.2×	65 0.7×	110 1.3×	22 0.3×	33 0.5×	9	234
Katja Mehlis Germany	7	270 0.9×	149 1.7×	98 1.1×	123 1.7×	26 0.4×	34	424
Lillie D. Shockney United States	9	82 0.3×	163 1.8×	423 4.9×	40 0.6×	129 1.9×	34	580
C. Klabunde United States	12	128 0.4×	220 2.5×	430 5.0×	85 1.2×	44 0.6×	16	767
Leah Kroon United States	9	36 0.1×	166 1.9×	82 1.0×	30 0.4×	151 2.2×	13	375
Michelle Doose United States	11	55 0.2×	106 1.2×	186 2.2×	47 0.7×	126 1.8×	32	382

Countries citing papers authored by Kate Watabayashi

Since Specialization

Citations

This map shows the geographic impact of Kate Watabayashi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kate Watabayashi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kate Watabayashi more than expected).

Fields of papers citing papers by Kate Watabayashi

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kate Watabayashi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kate Watabayashi. The network helps show where Kate Watabayashi may publish in the future.

Co-authorship network of co-authors of Kate Watabayashi

This figure shows the co-authorship network connecting the top 25 collaborators of Kate Watabayashi. A scholar is included among the top collaborators of Kate Watabayashi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kate Watabayashi. Kate Watabayashi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Tawfik, Bernard, Kate Watabayashi, Ruth C. Carlos, et al.. (2025). Addressing Challenges in Research Aimed at Reducing Financial Toxicity Among Cancer Patients and Caregivers: An Example From the CREDIT Study (SWOG S1912CD). Cancer Control. 32. 2935762517–2935762517. 1 indexed citations

Watabayashi, Kate, et al.. (2024). A proactive financial navigation intervention in patients with newly diagnosed gastric and gastroesophageal junction adenocarcinoma. Supportive Care in Cancer. 32(3). 189–189. 4 indexed citations

Watabayashi, Kate, Deborah Delaney, Ruth C. Carlos, et al.. (2023). Assessment of financial screening and navigation capabilities at National Cancer Institute community oncology clinics. JNCI Cancer Spectrum. 7(5). 10 indexed citations

Hershman, Dawn L., Aasthaa Bansal, William E. Barlow, et al.. (2023). Intervention Nonadherence in the TrACER (S1415CD) Study: A Pragmatic Randomized Trial of a Standardized Order Entry for CSF Prescribing. JCO Oncology Practice. 19(12). 1160–1167. 1 indexed citations

Hershman, Dawn L., Aasthaa Bansal, Sean D. Sullivan, et al.. (2022). A Pragmatic Cluster-Randomized Trial of a Standing Order Entry Intervention for Colony-Stimulating Factor Use Among Patients at Intermediate Risk for Febrile Neutropenia. Journal of Clinical Oncology. 41(3). 590–598. 3 indexed citations

Watabayashi, Kate, Karma L. Kreizenbeck, Aasthaa Bansal, et al.. (2022). An evaluation of stakeholder engagement in comparative effectiveness research: lessons learned from SWOG S1415CD. Journal of Comparative Effectiveness Research. 11(18). 1313–1321. 1 indexed citations

Watabayashi, Kate, Karma L. Kreizenbeck, Gary H. Lyman, et al.. (2022). Successes and challenges of implementing a cancer care delivery intervention in community oncology practices: lessons learned from SWOG S1415CD. BMC Health Services Research. 22(1). 432–432. 2 indexed citations

Hershman, Dawn L., Aasthaa Bansal, Sean D. Sullivan, et al.. (2022). A pragmatic cluster-randomized trial of a standing physician order entry intervention for colony stimulating factor use among patients at intermediate risk for febrile neutropenia (SWOG S1415CD).. Journal of Clinical Oncology. 40(16_suppl). 1518–1518.

Ramsey, Scott D., Aasthaa Bansal, Sean D. Sullivan, et al.. (2022). A pragmatic cluster-randomized trial of a computerized clinical decision support system to improve colony stimulating factor prescribing for patients with cancer receiving myelosuppressive chemotherapy (SWOG S1415CD).. Journal of Clinical Oncology. 40(16_suppl). 1525–1525.

10.

Ramsey, Scott D., Aasthaa Bansal, Sean D. Sullivan, et al.. (2022). Effects of a Guideline-Informed Clinical Decision Support System Intervention to Improve Colony-Stimulating Factor Prescribing. JAMA Network Open. 5(10). e2238191–e2238191. 3 indexed citations

11.

Roth, Joshua A., Meghna S. Trivedi, Stacy W. Gray, et al.. (2021). Patient Knowledge and Expectations About Return of Genomic Results in a Biomarker-Driven Master Protocol Trial (SWOG S1400GEN). JCO Oncology Practice. 17(11). e1821–e1829. 7 indexed citations

12.

Watabayashi, Kate, Karen Overstreet, Kathleen D. Gallagher, et al.. (2020). A Pilot Study of a Comprehensive Financial Navigation Program in Patients With Cancer and Caregivers. Journal of the National Comprehensive Cancer Network. 18(10). 1366–1373. 64 indexed citations

13.

Sullivan, Sean D., Mark Gorman, Karma L. Kreizenbeck, et al.. (2019). Effective stakeholder engagement: design and implementation of a clinical trial (SWOG S1415CD) to improve cancer care. BMC Medical Research Methodology. 19(1). 27 indexed citations

14.

Watabayashi, Kate, Karen Overstreet, Alan Balch, et al.. (2019). A pilot study of a comprehensive financial navigation program in cancer patients and caregivers.. Journal of Clinical Oncology. 37(27_suppl). 174–174. 2 indexed citations

15.

Yezefski, Todd, et al.. (2018). Impact of trained oncology financial navigators on patient out-of-pocket spending.. PubMed. 24(5 Suppl). S74–S79. 85 indexed citations

16.

Watabayashi, Kate, Karma L. Kreizenbeck, Gary H. Lyman, et al.. (2018). Impact of clinic characteristics on the adoption of a guideline-based standing order algorithm and patient accrual in the pragmatic cluster-randomized trial SWOG S1415CD (NCT02728596).. Journal of Clinical Oncology. 36(30_suppl). 60–60. 1 indexed citations

17.

Shankaran, Veena, Kate Watabayashi, Hannah M. Linden, et al.. (2017). Pilot Feasibility Study of an Oncology Financial Navigation Program. Journal of Oncology Practice. 14(2). e122–e129. 164 indexed citations

18.

Drescher, Charles W., J. David Beatty, Robert G. Resta, et al.. (2016). The effect of referral for genetic counseling on genetic testing and surgical prevention in women at high risk for ovarian cancer: Results from a randomized controlled trial. Cancer. 122(22). 3509–3518. 5 indexed citations

19.

Andersen, M. Robyn, Jason D. Thorpe, Diana S.M. Buist, et al.. (2014). Cancer Risk Awareness and Concern among Women with a Family History of Breast or Ovarian Cancer. Behavioral Medicine. 42(1). 18–28. 12 indexed citations

20.

Karlan, Beth Y., Jason D. Thorpe, Kate Watabayashi, et al.. (2014). Use of CA125 and HE4 Serum Markers to Predict Ovarian Cancer in Elevated-Risk Women. Cancer Epidemiology Biomarkers & Prevention. 23(7). 1383–1393. 19 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact